SODIUM ACETATE is a Intravenous Injection, Solution, Concentrate in the Human Prescription Drug category. It is labeled and distributed by Fresenius Kabi Usa, Llc. The primary component is Sodium Acetate.
| Product ID | 63323-032_797a200b-7a83-7ab8-e053-2a91aa0abc6f |
| NDC | 63323-032 |
| Product Type | Human Prescription Drug |
| Proprietary Name | SODIUM ACETATE |
| Generic Name | Sodium Acetate |
| Dosage Form | Injection, Solution, Concentrate |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2017-10-30 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA206687 |
| Labeler Name | Fresenius Kabi USA, LLC |
| Substance Name | SODIUM ACETATE |
| Active Ingredient Strength | 4 meq/100mL |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |
| Marketing Start Date | 2017-10-30 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA206687 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2017-10-30 |
| Marketing Category | ANDA |
| Application Number | ANDA206687 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2018-10-29 |
| Marketing Category | ANDA |
| Application Number | ANDA206687 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2017-10-30 |
| Marketing End Date | 2018-10-29 |
| Ingredient | Strength |
|---|---|
| SODIUM ACETATE | 4 meq/100mL |
| SPL SET ID: | d7fabf08-d4e0-4bb5-8416-2e8ffe27c04b |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0409-3299 | Sodium Acetate | sodium acetate |
| 0409-7299 | Sodium Acetate | SODIUM ACETATE |
| 51754-9995 | Sodium Acetate | Sodium Acetate |
| 63323-032 | SODIUM ACETATE | SODIUM ACETATE |
| 69784-230 | SODIUM ACETATE | SODIUM ACETATE |
| 69784-231 | SODIUM ACETATE | SODIUM ACETATE |
| 0517-5023 | Sodum Acetate | Sodium Acetate |